Linden Advisors’s RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share RCFA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-74,999
Closed -$7.37K 492
2023
Q1
$7.37K Hold
74,999
﹤0.01% 439
2022
Q4
$6.22K Hold
74,999
﹤0.01% 527
2022
Q3
$12K Hold
74,999
﹤0.01% 637
2022
Q2
$23K Hold
74,999
﹤0.01% 661
2022
Q1
$28K Buy
+74,999
New +$35.8K ﹤0.01% 697

Other funds holding RCFA.WS

Linden Advisors's RCFA.WS Position: Q2 2023 in Review

Linden Advisors sold out of RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (RCFA.WS) in Q2 2023, closing a stake of 74,999 shares — an estimated $7.37K sold.

Linden Advisors first reported a position in RCFA.WS in Q1 2022 and held it in 5 quarters. The position peaked at $28K in Q1 2022. 36 funds tracked by Wall St. Rank hold RCFA.WS as of Q2 2023.

  • Linden Advisors reported no remaining RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q2 2023 after selling out during the quarter.
  • Linden Advisors sold 74,999 RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q2 2023, an estimated $7.37K.
  • Linden Advisors first reported a position in RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q1 2022 and held it in 5 quarters.
  • Linden Advisors's RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $28K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q2 2023.

Based on Linden Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.